SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (123)5/24/2003 1:29:07 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 126
 
WSJ article on Dendritic cells based cancer vaccines. Interesting that DNA/DNDN are testing Avastin-Provenge combination in refractory prostate cancer, PII. While anti-VEGF may not work alone in PC, and IF Provenge is for real, this nontoxic combination may at the end work well (long term benefit)???

Miljenko